Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selepressin Phase 2a in Early Septic Shock
NCT01000649Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2009
- Primary completion
- Aug 2011
- Modality
- Peptides
- Countries
- 4
01
Overview
A Phase 2 trial of selepressin in septic shock, sponsored by Ferring Pharmaceuticals. Started Nov 2009; status: completed.
02
Drugs
selepressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01000649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000649.